Annual Shareholders Equity
$1.59 B
-$487.73 M-23.47%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual stockholders equity is $1.59 billion, with the most recent change of -$487.73 million (-23.47%) on December 31, 2023.
- During the last 3 years, VIR annual shareholders equity has risen by +$873.38 million (+121.84%).
- VIR annual shareholders equity is now -23.47% below its all-time high of $2.08 billion, reached on December 31, 2022.
Performance
VIR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.24 B
-$192.94 M-13.46%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly stockholders equity is $1.24 billion, with the most recent change of -$192.94 million (-13.46%) on September 30, 2024.
- Over the past year, VIR quarterly shareholders equity has dropped by -$192.94 million (-13.46%).
- VIR quarterly shareholders equity is now -42.29% below its all-time high of $2.15 billion, reached on September 30, 2022.
Performance
VIR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VIR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.5% | -13.5% |
| 3 y3 years | +121.8% | -37.0% |
| 5 y5 years | +987.5% | -37.0% |
VIR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.5% | +11.1% | -42.3% | at low |
| 5 y | 5-year | -23.5% | +275.1% | -42.3% | +226.2% |
| alltime | all time | -23.5% | +987.5% | -42.3% | +541.9% |
Vir Biotechnology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.24 B(-13.5%) |
| Jun 2024 | - | $1.43 B(-7.3%) |
| Mar 2024 | - | $1.55 B(-2.7%) |
| Dec 2023 | $1.59 B(-23.5%) | $1.59 B(-5.1%) |
| Sep 2023 | - | $1.68 B(-7.5%) |
| Jun 2023 | - | $1.81 B(-8.1%) |
| Mar 2023 | - | $1.97 B(-5.2%) |
| Dec 2022 | $2.08 B(+45.1%) | $2.08 B(-3.3%) |
| Sep 2022 | - | $2.15 B(+10.1%) |
| Jun 2022 | - | $1.95 B(-2.4%) |
| Mar 2022 | - | $2.00 B(+39.8%) |
| Dec 2021 | $1.43 B | $1.43 B(+63.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $876.27 M(+18.8%) |
| Jun 2021 | - | $737.33 M(+13.3%) |
| Mar 2021 | - | $650.95 M(-9.2%) |
| Dec 2020 | $716.85 M(+69.1%) | $716.85 M(-11.8%) |
| Sep 2020 | - | $812.36 M(+44.1%) |
| Jun 2020 | - | $563.78 M(+48.2%) |
| Mar 2020 | - | $380.33 M(-10.3%) |
| Dec 2019 | $423.94 M(-336.6%) | $423.94 M(-251.0%) |
| Sep 2019 | - | -$280.80 M(-169.9%) |
| Jun 2019 | - | $401.45 M(-324.1%) |
| Dec 2018 | -$179.18 M(+160.0%) | -$179.18 M |
| Dec 2017 | -$68.92 M | - |
FAQ
- What is Vir Biotechnology annual stockholders equity?
- What is the all time high annual shareholders equity for Vir Biotechnology?
- What is Vir Biotechnology annual shareholders equity year-on-year change?
- What is Vir Biotechnology quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Vir Biotechnology?
- What is Vir Biotechnology quarterly shareholders equity year-on-year change?
What is Vir Biotechnology annual stockholders equity?
The current annual shareholders equity of VIR is $1.59 B
What is the all time high annual shareholders equity for Vir Biotechnology?
Vir Biotechnology all-time high annual stockholders equity is $2.08 B
What is Vir Biotechnology annual shareholders equity year-on-year change?
Over the past year, VIR annual stockholders equity has changed by -$487.73 M (-23.47%)
What is Vir Biotechnology quarterly stockholders equity?
The current quarterly shareholders equity of VIR is $1.24 B
What is the all time high quarterly shareholders equity for Vir Biotechnology?
Vir Biotechnology all-time high quarterly stockholders equity is $2.15 B
What is Vir Biotechnology quarterly shareholders equity year-on-year change?
Over the past year, VIR quarterly stockholders equity has changed by -$192.94 M (-13.46%)